Skip to main content
Caplight Logo









Invitrolize

Invitrolize

Private
BelvauxHealthcare & Life Scienceshttps://invitrolize.com/

Last Round

Seed

May 14, 2025

Total Funding Raised

$1.28M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Invitrolize is a biotechnology company that provides advanced 3D in vitro models of the human alveolar barrier to identify respiratory sensitizers and irritants for the pharmaceutical, cosmetic, chemical, and consumer goods industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Compliance, Fashion & Beauty, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

in vitro testinganimal testing alternativestoxicological testingcontract research organizationCROskin sensitizationreconstructed human epidermiscruelty-free testingregulatory compliancesafety assessmenthuman cell-based assaysNAMsnew approach methodologiesbiotech services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Invitrolize Comparables

Compare Invitrolize with similar companies based on industry and business-model similarity.

Invitrolize comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ImmunoSearch
94%
XCellR8
88%
SenzaGen AB
80%

Invitrolize Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 14, 2025
AcceleratorOct 19, 2023

Key People

Founding team and executive leadership

Asier Sesma

Chief Operating Officer

Executive Team

Invitrolize Investors

Notable investors and investment history

Invitrolize investors
InvestorRounds
Expon CapitalSeed
Luxembourg's Ministry of the EconomyAccelerator
Fit 4 StartAccelerator, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 665% MoM, from 191 to 1.5K.

  • May 20, 2026

    Monthly visitors increased 79% MoM.

Invitrolize Filings

Explore SEC and related filing metadata, where available.

Invitrolize filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Invitrolize's valuation, stock price, and market status.

Is INVITROLIZE a public or private company?

INVITROLIZE is a private company.

What is the current stock price of INVITROLIZE?

INVITROLIZE is a private company with no public stock price. No recent secondary market data is available.

How much is INVITROLIZE worth (valuation)?

Valuation information for INVITROLIZE is not publicly available.

Can I buy INVITROLIZE stock?

INVITROLIZE shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was INVITROLIZE's last funding round?

INVITROLIZE's most recent funding round was Seed on May 8, 2025.

Who are the main investors in INVITROLIZE?

Key investors in INVITROLIZE include Expon Capital.

Will INVITROLIZE IPO soon?

No public IPO plans have been announced for INVITROLIZE.

How can I track INVITROLIZE secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor INVITROLIZE's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBelvaux
Employee Range5
Year Founded2021
Last FundingMay 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?